CAMBRIDGE, England, and GHENT, Belgium, June 27, 2023 /PRNewswire/ — Mestag Therapeutics (‘Mestag’), an immunotherapy company focusing on fibroblast-immune interactions, and VIB, the leading life science research institute in Flanders, today announced entering into an agreement under…